High Blood Pressure
Study Name: High Blood Pressure
Clinics: Manchester EPU
Therapy Area: Hypertension
Gender and Age: Males & Females Aged 18 - 65
MAC Clinical Research is currently conducting a clinical trial to evaluate an investigational drug for hypertension (high blood pressure). Untreated hypertension can increase the risk of several other health problems, including heart attack, so it is important to treat high blood pressure. While several treatments already exist, many patients are not adequately controlled on these medications and research to discover better treatments is needed.
This trial will test the safety and efficacy of the investigational study drug compared to placebo (inactive pill) on patients with high blood pressure. The study medication or placebo will be given to you once and will be given as 1 injection with a thin needle under the skin of either your abdomen, upper arm or thigh.
There will be 11 visits to the clinic and 2 overnight stays over a period of up to 20 weeks. There is no certainty that you will receive any medical benefit from taking part in this study.
Key Inclusion Criteria:
Male or female aged 18 to 65
Diagnosis of hypertension
BMI between 18 and 35 kg/m2, inclusive
Key Exclusion Criteria:
Diagnosis or early onset diabetes
Other unstable health condition
Other eligibility criteria will apply. Please contact MAC for more information.
Any other information
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.